» Articles » PMID: 24141640

Differential White Cell Count and Incident Type 2 Diabetes: the Insulin Resistance Atherosclerosis Study

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2013 Oct 22
PMID 24141640
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: White cell count has been shown to predict incident type 2 diabetes, but differential white cell count has received scant attention. We examined the risk of developing diabetes associated with differential white cell count and neutrophil:lymphocyte ratio and the effect of insulin sensitivity and subclinical inflammation on white cell associations.

Methods: Incident diabetes was ascertained in 866 participants aged 40-69 years in the Insulin Resistance Atherosclerosis Study after a 5 year follow-up period. The insulin sensitivity index (SI) was measured by the frequently sampled IVGTT.

Results: C-reactive protein was directly and independently associated with neutrophil (p < 0.001) and monocyte counts (p < 0.01) and neutrophil:lymphocyte ratio (p < 0.001), whereas SI was inversely and independently related to lymphocyte count (p < 0.05). There were 138 (15.9%) incident cases of diabetes. Demographically adjusted ORs for incident diabetes, comparing the top and bottom tertiles of white cell (1.80 [95% CI 1.10, 2.92]), neutrophil (1.67 [1.04, 2.71]) and lymphocyte counts (2.30 [1.41, 3.76]), were statistically significant. No association was demonstrated for monocyte count (1.18 [0.73, 1.90]) or neutrophil:lymphocyte ratio (0.89 [0.55, 1.45]). White cell and neutrophil associations were no longer significant after further adjusting for family history of diabetes, fasting glucose and smoking, but the OR comparing the top and bottom tertiles of lymphocyte count remained significant (1.96 [1.13, 3.37]). This last relationship was better explained by SI rather than C-reactive protein.

Conclusions/interpretation: A lymphocyte association with incident diabetes, which was the strongest association among the major white cell types, was partially explained by insulin sensitivity rather than subclinical inflammation.

Citing Articles

The prognostic value of the systemic immunity-inflammation index for cardiovascular and all-cause mortality in cardiovascular disease patients with diabetes or prediabetes.

Long Z, Du J, Hu J, Xiao Y, Hou C J Diabetes Investig. 2024; 16(3):510-520.

PMID: 39718039 PMC: 11871382. DOI: 10.1111/jdi.14383.


Key biomarkers in type 2 diabetes patients: A systematic review.

Le T, Bright R, Truong V, Li J, Juneja R, Vasilev K Diabetes Obes Metab. 2024; 27(1):7-22.

PMID: 39355932 PMC: 11618249. DOI: 10.1111/dom.15991.


Systemic Inflammatory Indices and Liver Dysfunction in Turner Syndrome Patients: A Retrospective Case-control Study.

Zaegel N, Brahimaj R, Battaglia-Hsu S, Lamiral Z, Feigerlova E J Endocr Soc. 2024; 8(7):bvae099.

PMID: 38831865 PMC: 11145559. DOI: 10.1210/jendso/bvae099.


The role of peripheral white blood cell counts in the association between central adiposity and glycemic status.

Liu F, Li Y, Li W, Feng R, Zhao H, Chen J Nutr Diabetes. 2024; 14(1):30.

PMID: 38760348 PMC: 11101409. DOI: 10.1038/s41387-024-00271-9.


White blood cells and type 2 diabetes: A Mendelian randomization study.

Bi Y, Gao Y, Xie Y, Zhou M, Liu Z, Tian S PLoS One. 2024; 19(3):e0296701.

PMID: 38427644 PMC: 10906821. DOI: 10.1371/journal.pone.0296701.


References
1.
Facchini F, Hollenbeck C, Chen Y, Chen Y, Reaven G . Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med. 1992; 232(3):267-72. DOI: 10.1111/j.1365-2796.1992.tb00582.x. View

2.
Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

3.
Schmidt M, Duncan B, Sharrett A, Lindberg G, Savage P, Offenbacher S . Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999; 353(9165):1649-52. DOI: 10.1016/s0140-6736(99)01046-6. View

4.
Freeman D, Norrie J, Sattar N, Neely R, Cobbe S, Ford I . Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation. 2001; 103(3):357-62. DOI: 10.1161/01.cir.103.3.357. View

5.
Dessein P, Joffe B, Stanwix A, Botha A, Moomal Z . The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J Rheumatol. 2002; 29(3):462-6. View